AI IntelligenceJul 24, 2026M&A
Article
Großes Pharmaunternehmen -> Biotech AI Startup
A large pharmaceutical company is in talks to acquire a biotech startup specializing in AI-driven drug discovery for around $900 million. The startup recently completed a successful Series B round. The acquisition would expand the pharma company's AI research capabilities in drug discovery.
Data Cube AI EditorialSource: Crunchbase News
01
Source Brief
A large pharmaceutical company is in talks to acquire a biotech startup specializing in AI-driven drug discovery for around $900 million. The startup recently completed a successful Series B round. The acquisition would expand the pharma company's AI research capabilities in drug discovery.